Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region - Global Forecasts to 2028

Abstract
The global empty capsules market size is projected to reach USD 4.9 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 9.3% during the forecast period. Factors such as increasing use of nutraceuticals and benefits associated with empty capsules, are driving the market growth at a faster pace.

“The non-gelatin capsules segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”

On the basis of type, the empty capsules market is segmented into gelatin capsules, and non-gelatin capsules. The non-gelatin capsules segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of vegetarian products. This is likely to have a positive impact on segmental growth.

“The immediate-release capsules segment is expected to hold a dominant share in 2023.”

Based on the functionality, the market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate release capsules segment is expected to grow at a faster pace during the forecast period due to its advantages such as higher bioavailability, easy digestion, and low cost.

“In 2022, the antibiotic & antibacterial drugs segment held a dominant share.”

Based on therapeutic application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The antibiotic & antibacterial drugs segment held a dominant share of the empty capsules market. Development of new antibiotics in capsule dosage form to project the market growth.

“The nutraceutical industry segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”

Based on end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and reference laboratories. The nutraceutical industry segment to grow at the highest CAGR during the forecast period. The growing use of dietary supplements is one of the major factors anticipated to project market growth.

“Asia Pacific region is likely to grow at faster pace.”

The empty capsules market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of empty capsules market. The dominance of the region is attributable to various factors such as the presence of dominant and key market players in the region coupled with increasing use of dietary supplements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the low cost of manufacturing, rising scientific research in the region, and the emergence of new market players in the empty capsules market.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 90%, and Demand Side - 10%
•By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
•By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:
•Capsugel (US)
•ACG Worldwide (India)
•Mitsubishi Chemical Holding Corporation (US)
•CapsCanada Corporation (Canada)
•Natural Capsules (India)
•Suheung Co., Ltd. (South Korea)
•Nectar Lifesciences Ltd. (India)
•Qingdao Yiqing Medicinal Capsule (China)
•Shanxi Guangsheng Medicinal Capsule (China)
•Health Caps India (India)
•Medi-Caps (India)
•Snail Pharma Industry (China)
•Roxlor (US)
•Sunil Healthcare (India)
•BioCaps Enterprise (US)
•Bright Pharma Caps (US)
•Comed Chemicals (India)
•Saviour Caps (India)
•Fortcaps Healthcare (India)
•Shaoxing Zhongya Capsule (China)
•Erawat Pharma (India)
•Farmacapsulas (Colombia)
•Zhejiang Yuexi Capsule (Taiwan)
•LFA Machines Oxfords (US)
•Shaoxing Kangke (China)
•Shree Pharma Caps (India)

Research Coverage:
This report provides a detailed picture of the empty capsules market. It aims at estimating the size and future growth potential of the market across different segments, such as type, functionality, therapeutic application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Content
Table of Contents

1INTRODUCTION33
1.1STUDY OBJECTIVES33
1.2MARKET DEFINITION33
1.2.1INCLUSIONS AND EXCLUSIONS34
1.3MARKET SCOPE34
FIGURE 1EMPTY CAPSULES MARKET SEGMENTATION34
1.3.1YEARS CONSIDERED35
1.4CURRENCY CONSIDERED35
1.5LIMITATIONS35
1.6STAKEHOLDERS36
1.7SUMMARY OF CHANGES36
1.7.1RECESSION IMPACT36
2RESEARCH METHODOLOGY37
2.1RESEARCH APPROACH37
FIGURE 2RESEARCH DESIGN37
2.1.1SECONDARY RESEARCH38
2.1.2PRIMARY RESEARCH38
FIGURE 3EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS39
2.2MARKET ESTIMATION METHODOLOGY39
FIGURE 4EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022)39
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202240
FIGURE 6MARKET VOLUME ESTIMATION, 202240
2.2.1INSIGHTS FROM PRIMARY EXPERTS41
FIGURE 7INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS41
2.3MARKET GROWTH RATE PROJECTIONS42
FIGURE 8EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS43
2.4DATA TRIANGULATION44
FIGURE 9DATA TRIANGULATION METHODOLOGY44
2.5RESEARCH ASSUMPTIONS45
2.6RISK ANALYSIS45
3EXECUTIVE SUMMARY46
FIGURE 10EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)46
FIGURE 11EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)47
FIGURE 12EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)47
FIGURE 13EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)48
FIGURE 14GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET49
4PREMIUM INSIGHTS50
4.1EMPTY CAPSULES MARKET OVERVIEW50
FIGURE 15INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH50
4.2NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022)50
FIGURE 16GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 202250
4.3EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 202851
FIGURE 17ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD51
4.4EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES51
FIGURE 18ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD51
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 19EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES52
TABLE 1EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS53
5.2.1.1Increasing demand for nutraceuticals53
5.2.1.2Growth in pharmaceutical market and increasing number of clinical trials and R&D activities54
5.2.1.3Advancements in capsule delivery technologies54
5.2.1.4Benefits of capsules over other dosage forms55
5.2.2RESTRAINTS55
5.2.2.1Cultural practices and dietary restrictions55
5.2.3OPPORTUNITIES55
5.2.3.1Expansion of capsule production in emerging countries55
5.2.3.2Development of halal gelatin and vegetarian capsules56
5.2.4CHALLENGES57
5.2.4.1Rising prices and lower availability of raw materials in gelatin industry57
5.3TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES58
FIGURE 20REVENUE SHIFT AND NEW REVENUE POCKETS58
5.4PRICING ANALYSIS58
TABLE 2AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)58
5.5TECHNOLOGY ANALYSIS59
5.5.1ENTERIC CAPSULE TECHNOLOGIES59
5.5.2PROTEIN DELIVERY CAPSULE TECHNOLOGIES59
5.6VALUE CHAIN ANALYSIS60
FIGURE 21EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS60
5.7ECOSYSTEM ANALYSIS61
FIGURE 22ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET61
TABLE 3ROLE IN ECOSYSTEM62
5.8PORTER’S FIVE FORCES ANALYSIS62
TABLE 4EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS62
5.8.1THREAT OF NEW ENTRANTS62
5.8.2THREAT OF SUBSTITUTES63
5.8.3BARGAINING POWER OF SUPPLIERS63
5.8.4BARGAINING POWER OF BUYERS63
5.8.5INTENSITY OF COMPETITIVE RIVALRY63
5.9KEY STAKEHOLDERS AND BUYING CRITERIA63
FIGURE 23INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES63
FIGURE 24KEY BUYING CRITERIA FOR EMPTY CAPSULES64
5.10PATENT ANALYSIS65
FIGURE 25PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 202365
TABLE 5LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET66
5.11TRADE ANALYSIS67
TABLE 6EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)67
TABLE 7IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)67
5.12REGULATORY ANALYSIS68
5.13PHARMACEUTICAL GELATIN MARKET70
5.14INDUSTRY TRENDS70
5.14.1RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES70
5.14.2GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES71
6EMPTY CAPSULES MARKET, BY TYPE72
6.1INTRODUCTION73
TABLE 8EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)73
TABLE 9EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)73
6.2GELATIN CAPSULES74
TABLE 10GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)74
TABLE 11GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)75
TABLE 12GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)75
TABLE 13NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)75
TABLE 14EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)76
TABLE 15ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)76
6.2.1PORCINE GELATIN76
6.2.1.1Porcine gelatin segment to dominate market76
TABLE 16PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)77
TABLE 17NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)77
TABLE 18EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)78
TABLE 19ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)78
6.2.2BOVINE-DERIVED GELATIN78
6.2.2.1Bovine-derived gelatin widely accepted in halal pharmaceuticals market78
TABLE 20BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)79
TABLE 21NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)79
TABLE 22EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)80
TABLE 23ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)80
6.2.3BONE MEAL80
6.2.3.1Bone meal gelatin gained importance in recent years80
TABLE 24BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)81
TABLE 25NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)81
TABLE 26EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)82
TABLE 27ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)82
6.2.4OTHER GELATIN SOURCES82
TABLE 28OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)83
TABLE 29NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)83
TABLE 30EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
TABLE 31ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
6.3NON-GELATIN CAPSULES84
TABLE 32NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)85
TABLE 33NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)85
TABLE 34NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)86
TABLE 35NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
TABLE 36EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
TABLE 37ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)87
6.3.1HYDROXYPROPYL METHYLCELLULOSE87
6.3.1.1HPMC dominates non-gelatin capsules market87
TABLE 38HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)88
TABLE 39NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
TABLE 40EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
TABLE 41ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
6.3.2PULLULAN AND STARCH89
6.3.2.1High manufacturing costs offset advantageous aspects of pullulan and starch89
TABLE 42PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)90
TABLE 43NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
TABLE 44EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)91
TABLE 45ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)91
7EMPTY CAPSULES MARKET, BY FUNCTIONALITY92
7.1INTRODUCTION93
TABLE 46EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)93
7.2IMMEDIATE-RELEASE CAPSULES93
7.2.1INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET93
TABLE 47IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)94
TABLE 48NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 49EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 50ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)95
7.3SUSTAINED-RELEASE CAPSULES95
7.3.1RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET95
TABLE 51SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)96
TABLE 52NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)96
TABLE 53EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)97
TABLE 54ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)97
7.4DELAYED-RELEASE CAPSULES97
7.4.1GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH97
TABLE 55DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)98
TABLE 56NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 57EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 58ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)99
8EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION100
8.1INTRODUCTION101
TABLE 59EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)101
8.2ANTIBIOTIC AND ANTIBACTERIAL DRUGS101
8.2.1EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET101
TABLE 60EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION)102
TABLE 61NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)102
TABLE 62EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)103
TABLE 63ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)103
8.3DIETARY SUPPLEMENTS103
8.3.1RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH103
TABLE 64EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION)104
TABLE 65NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 66EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)105
TABLE 67ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)105
8.4ANTACID AND ANTIFLATULENT PREPARATIONS105
8.4.1INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET105
TABLE 68EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)106
TABLE 69NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)106
TABLE 70EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)107
TABLE 71ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)107
8.5ANTIANEMIC PREPARATIONS107
8.5.1RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH107
TABLE 72EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)108
TABLE 73NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)108
TABLE 74EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 75ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)109
8.6ANTI-INFLAMMATORY DRUGS109
8.6.1RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH109
TABLE 76EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION)110
TABLE 77NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)110
TABLE 78EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)111
TABLE 79ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)111
8.7CARDIOVASCULAR THERAPY DRUGS111
8.7.1RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH111
TABLE 80EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION)112
TABLE 81NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 82EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)113
TABLE 83ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)113
8.8COUGH AND COLD DRUGS113
8.8.1GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH113
TABLE 84EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION)114
TABLE 85NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 86EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)115
TABLE 87ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)115
8.9OTHER THERAPEUTIC APPLICATIONS115
TABLE 88EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)116
TABLE 89NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)116
TABLE 90EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 91ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)117
9EMPTY CAPSULES MARKET, BY END USER118
9.1INTRODUCTION119
TABLE 92EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)119
9.2PHARMACEUTICAL INDUSTRY119
9.2.1INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH119
TABLE 93EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)120
TABLE 94NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 95EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 96ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)121
9.3NUTRACEUTICAL INDUSTRY121
9.3.1INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH121
TABLE 97EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)122
TABLE 98NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)122
TABLE 99EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 100ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)123
9.4COSMETICS INDUSTRY123
9.4.1GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS123
TABLE 101EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)124
TABLE 102NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)124
TABLE 103EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)125
TABLE 104ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)125
9.5RESEARCH LABORATORIES125
9.5.1RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH125
TABLE 105EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)126
TABLE 106NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 107EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 108ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)127
10EMPTY CAPSULES MARKET, BY REGION128
10.1INTRODUCTION129
TABLE 109EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)129
TABLE 110EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)129
10.2NORTH AMERICA130
FIGURE 26NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT131
TABLE 111NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)131
TABLE 112NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 113NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 114NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 115NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)133
TABLE 116NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)133
TABLE 117NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)134
10.2.1US134
10.2.1.1US to dominate North American market during forecast period134
TABLE 118US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)135
TABLE 119US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)135
TABLE 120US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)135
TABLE 121US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)136
TABLE 122US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)136
TABLE 123US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)137
10.2.2CANADA137
10.2.2.1Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth137
TABLE 124CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 125CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 126CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 127CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)139
TABLE 128CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)139
TABLE 129CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)140
10.2.3NORTH AMERICA: RECESSION IMPACT140
10.3EUROPE140
TABLE 130EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)141
TABLE 131EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 132EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 133EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)142
TABLE 134EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)142
TABLE 135EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)142
TABLE 136EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)143
10.3.1GERMANY143
10.3.1.1Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules143
TABLE 137GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)144
TABLE 138GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)144
TABLE 139GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)144
TABLE 140GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)145
TABLE 141GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)145
TABLE 142GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)146
10.3.2UK146
10.3.2.1Rising adoption of generics to drive market growth146
TABLE 143UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)146
TABLE 144UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)147
TABLE 145UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)147
TABLE 146UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)147
TABLE 147UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)148
TABLE 148UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)148
10.3.3FRANCE148
10.3.3.1High demand for pharmaceutical products to drive market growth148
TABLE 149FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 150FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 151FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)150
TABLE 152FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)150
TABLE 153FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)150
TABLE 154FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)151
10.3.4ITALY151
10.3.4.1Growing presence of small and medium-sized CMOs likely to drive market151
TABLE 155ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)152
TABLE 156ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)152
TABLE 157ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)152
TABLE 158ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)153
TABLE 159ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)153
TABLE 160ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)154
10.3.5SPAIN154
10.3.5.1Consolidation of biotechnology sector and availability of government support to drive growth154
TABLE 161SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)154
TABLE 162SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)155
TABLE 163SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)155
TABLE 164SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)155
TABLE 165SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)156
TABLE 166SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)156
10.3.6REST OF EUROPE156
TABLE 167REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)157
TABLE 168REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)157
TABLE 169REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)158
TABLE 170REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)158
TABLE 171REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)159
TABLE 172REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)159
10.3.7EUROPE: RECESSION IMPACT159
10.4ASIA PACIFIC160
FIGURE 27ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT161
TABLE 173ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 174ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)162
TABLE 175ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)162
TABLE 176ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)162
TABLE 177ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)163
TABLE 178ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)163
TABLE 179ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)164
10.4.1CHINA164
10.4.1.1Low manufacturing costs on account of availability of raw materials to accelerate growth164
TABLE 180CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 181CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 182CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 183CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)166
TABLE 184CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)166
TABLE 185CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)167
10.4.2JAPAN167
10.4.2.1Japan to be largest market for empty capsules in Asia Pacific167
TABLE 186JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 187JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 188JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 189JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)169
TABLE 190JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)169
TABLE 191JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)170
10.4.3INDIA170
10.4.3.1Increased exports of empty capsules to drive market growth170
TABLE 192INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)171
TABLE 193INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)171
TABLE 194INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)171
TABLE 195INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)172
TABLE 196INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)172
TABLE 197INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)173
10.4.4REST OF ASIA PACIFIC173
TABLE 198REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)173
TABLE 199REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)174
TABLE 200REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)174
TABLE 201REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)174
TABLE 202REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)175
TABLE 203REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)175
10.4.5ASIA PACIFIC: RECESSION IMPACT175
10.5LATIN AMERICA176
10.5.1STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH176
TABLE 204LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)176
TABLE 205LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 206LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 207LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)177
TABLE 208LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)178
TABLE 209LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)178
10.5.2LATIN AMERICA: RECESSION IMPACT178
10.6MIDDLE EAST & AFRICA179
10.6.1GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET179
TABLE 210MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)179
TABLE 211MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)180
TABLE 212MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)180
TABLE 213MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)180
TABLE 214MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)181
TABLE 215MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)181
10.6.2MIDDLE EAST & AFRICA: RECESSION IMPACT182
11COMPETITIVE LANDSCAPE183
11.1INTRODUCTION183
11.2RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS183
FIGURE 28EMPTY CAPSULES MARKET: STRATEGIES ADOPTED184
11.3MARKET SHARE ANALYSIS185
FIGURE 29EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)185
TABLE 216EMPTY CAPSULES MARKET: DEGREE OF COMPETITION185
11.4REVENUE ANALYSIS187
FIGURE 30REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022)187
11.5COMPANY EVALUATION MATRIX187
11.5.1STARS187
11.5.2EMERGING LEADERS187
11.5.3PERVASIVE PLAYERS187
11.5.4PARTICIPANTS188
FIGURE 31EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022188
11.6COMPANY EVALUATION MATRIX FOR START-UPS/SMES189
11.6.1PROGRESSIVE COMPANIES189
11.6.2STARTING BLOCKS189
11.6.3RESPONSIVE COMPANIES189
11.6.4DYNAMIC COMPANIES189
FIGURE 32EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022190
11.7COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS191
11.7.1OVERALL COMPANY FOOTPRINT (25 COMPANIES)191
TABLE 217OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS191
11.7.2INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)192
TABLE 218INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS192
11.7.3REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)193
TABLE 219REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS193
11.7.4OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)194
TABLE 220OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS194
11.8COMPETITIVE BENCHMARKING OF START-UPS/SMES195
TABLE 221EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES195
TABLE 222EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES196
11.9COMPETITIVE SCENARIO AND TRENDS196
11.9.1PRODUCT LAUNCHES196
TABLE 223EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023196
11.9.2DEALS197
TABLE 224EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023197
11.9.3OTHER DEVELOPMENTS197
TABLE 225EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023197